Tim Watkins

CMO & Head of Development, Contineum Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.3M

Companies

Latest trade

Jun 30, 2026

Companies

Contineum Therapeutics, Inc.CMO & Head of Development −$0.3M

Trades

CTNM Sold 10,833 shares at $16.02 · planned $0.2M Jun 30

CTNM Sold 3,611 shares at $15.02 · planned $0.1M Mar 2

CTNM Sold 3,611 shares at $14.18 · planned $0.1M Jan 28

CTNM Sold 3,611 shares at $12.06 · planned $0.0M Dec 29

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.